Differential response to low-fat diet between low and normal HDL- cholesterol subjects

Journal of Lipid Research

Volumn 41, Issue 3, 2000, Pages 321-328

  Asztalos, Bela ^a   Lefevre, Michael ^b   Wong, Laurence ^a   Foster, Theda A ^a   Tulley, Richard ^b   Windhauser, Marlene ^b   Zhang, Wenwu ^a   Roheim, Paul S ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

CHD; Cholesterol; Diet; HDL; HDL subpopulations; LDIL; LDL C HDL C ratio; Lipids; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET; FAT INTAKE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MALE; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEIN A-I; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIETARY FATS; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; PLACEBOS;

EID: 0034029923     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Miller, N. E., D. S. Thelle, O. H. Forde, and O. D. Mjos. 1977. The Tromso heart study. High density lipoprotein and coronary heart disease: a prospective case control study. Lancet. 1: 965-967.
2. Castelli, W. P., R. J. Garrison, P. W. F. Wilson, R. D. Abbott, S. Kalousidan, and W. B. Kannel. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. J. Am. Med. Assoc. 256: 2835-2838.
3. Gordon, D. J., and B. M. Rifkind. 1989. Current concepts: high density lipoproteins: the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
4. Lavie, C. J., J. H. O'Keefe, L. Blonde, and G. T. Gau. 1990. High-density lipoprotein cholesterol. Coron. Artery Dis. 87: 36-44.
5. Heiss, G., N. J. Johnson, S. Reiland, C. E. Davis, and H. A. Tyroler. 1980. The epidemiology of plasma high-density lipoprotein cholesterol levels. Circulation. 62(suppl IV): 116-136.
6. Breslow, J. L. 1989. Familial disorders of high-density lipoprotein metabolism. In The Metabolic Basis of Inherited Disease, 6th ed. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York, NY. 2031-2052.
7. Brooks-Wilson, A., M. Marcil, S. M. Clee, Lin-Hua Zhang, K. Roomp, M. Van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. F. Molhuizen, O. Loubser, B. F. F. Ouclette, K. Fichter, K. J. D. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. P. Kastelein, J. Genest, Jr., and M. R. Hayden, 1999. Mutations in ABCl in Tangier disease and familial high-density lipoprotein deficiency. Nature Genet. 22: 336-345.
8. Bodzioch, M., E. Orsó, J. Klucken, T. Langmann, A. Böucher, W. Diederich, W. Drobnik, S. Barlage, C. Büchler, M. Porsch-Özcürümez, W. F. Kaminski, H. W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K. J. Lackner, and G. Schmitz. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nature Genet. 22: 347-351.
9. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J-C. Piette, J-F. Deleuze, H. B. Brewer, N. Duverger, P. Denèfle, and G. Assmann. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nature Genet. 22: 352-355.
10. Fredrickson, D. S., P. H. Altrocchi, L. V. Avioli, D. S. Goodman, and H. C. Goodman. 1961. Tangier disease - combined clinical staff conference at the National Institutes of Health. Ann. Intern. Med. 55: 1016-1031.
11. Assmann, G., G. Schmitz, and H. B. Brewer, Jr. 1989. Familial high density lipoprotein deficiency: Tangier disease. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. I. Beaudet, W. S. Sly, and D. Valle editors. McGraw-Hill, New York, NY. 1267-1282.
12. Hayek, T., Y. Ito, N. Azrolan, R. B. Verdery, K. Aalto-Setala, A. Walsh, and J. L. Breslow. 1993. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (apo) A-I. J. Clin. Invest. 91: 1665-1699.
13. Hayek, T., T. Chajek-Shaul, A. Walsh, N. Azrolan, and J. L. Breslow. 1991. Proburol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice. Arterioscler. Thromb. 11: 1295-1302.
14. American Heart Association. 1988. Dietary guidelines for healthy American adults: a statement for physicians and health professionals by the Nutrition Committee. Circulation. 77: 721A-724A.
15. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. 1993. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J. Am. Med. Assoc. 269: 3015-3023.
16. Brinton, E. A., S. Eisenberg, and J. L., Breslow. 1990. A low-fat diet decrease's high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J. Clin. Invest. 85: 144-151.
17. Mensink, R. P., and M. B. Katan. 1992. Effect of dietary fatty acids on scrum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler. Thromb. Vasc. Biol. 12: 911-919.
18. Schaefer, E. J., A. H. Lichtenstein, S. Lamon-Fava, J. H. Contois, Z. Li, H. Rasmussen, J. R. McNamara, and J. M. Ordovas. 1995. Efficacy of a National Cholesterol Education Program Step-2 Diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler. Thromb. Vasc. Biol. 15: 1079-1085.
19. Ginsberg, H. N., P. Kris-Etherton, B. Dennis, P. J. Elmer, A. Ershow, M. Lefevre, T. Pearson, P. Roheim, R. Ramakrishnan, R. Reed, K. Stewart, P. Stewart, K. Phillips, N. Anderson, for the DELTA Research Group. 1988. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects (The Delta Study. Protocol I). Arterioscler. Thromb. Vasc. biol. 18: 441-449.
20. Katan, M. B., S. M. Grundy, and W. C. Willett. 1997. Clinical Debate: Should a low-fat, high-carbohydrate diet be recommended for everyone? (Beyond low-fat diets). N. Engl. J. Med. 337: 563-566.
21. Grundy, S. M., D. S. Goodman, B. M. Rilkind, and J. I. Cleeman. 1989. The place of HDL in cholesterol management. Arch. Intern. Med. 149: 505-510.
22. Asztalos, B., C. H. Sloop, L. Wong, and P. S. Roheim. 1993. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. Biochim. Biophys. Acta. 1169: 291-300.
23. Asztalos, B. F., M. Lefevre, T. A. Foster, R. Tulley, M. Windhauser, L, Wong, and P. S. Roheim. 1997. Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations. Arterioscler. Thromb. Vasc. Biol. 17: 1885-1893.
24. Puchois, P., A. Kandoussi, P. Fievet, J. L. Fourrier, M. Bertrand, E. Koren, and J. C. Fruchart. 1987. Apolipoprolein A-I containing lipoproteins in coronary heart disease. Atherosclerosis. 68: 35-40.
25. Linn, S., M. Carroll, C. Johnson, R. Fulwood, W. Kalsbeek, and R. Briefel. 1993. High density lipoprotein cholesterol and alcohol consumption in United States while and black adults from NHANES-11. Am J. Public Health. 83(6): 811-816.
26. 2 + precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin. Chem. 28: 1379-88.
27. Johnston, R. F., S. C. Pickett, and D. L. Barker. 1990. Autoradiography using storage phosphor technology. Electrophoresis. 11: 355-360.
28. Milliken, G. A. and D. E. Johnson. 1990. Analysis of Messy Data, Vol. I: Designed Experiments. Chapman & Hall, New York, NY.
29. Ratkowskv, D. A., J. R. Alldredge, and J. W. Cotton. 1990. Analyzing balanced or unbalanced Latin squares and other repeated-measures designs for carryover effects using the GLM procedure. SAS User's Group International, Proceedings of the 15th Annual Conference, April 1-4; Nashville, TN. 1353-1358.
30. SAS Institute, I. 1989. SAS/STAT User's Guide. Vol. 2, Version 6, 4th ed. Cary, NC. 846.
31. Assmann, G., H. Schulte, A. von Eckardstein, and Y. Huang. 1996. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. (124 Suppl.): S11-S20.
32. Johansson, J., L. A. Carlson, C. Landou, and A. Hamsten. 1991. High density lipoproteins and coronary atherosclerosis. Arterioscler. Thromb. 11: 174-182.
33. Young, S. G., and C. J. Fielding. 1999. The ABCs of cholesterol efflux. Nature Genet. 22: 316-318.
34. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, and J. F. Oram. 1999. The Tangier disease gene product ABCl controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: R25-R31.
35. Busch, S. J., R. L. Barnhart, G. A. Martin, M. C. Fitzgerald, M. T. Yates, S. J. Mao, C. E. Thomas, and R. L. Jackson. 1994. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269: 16376-16382.
36. 2 in man. Atherosclerosis. 36:589-593.
37. Kinnunen, P. H. J., J. A. Virtanen, and P. Vainio. 1983. Lipoprotein lipase and hepatic endothelial lipase: their roles in plasma lipoprotein metabolism. Artheroscler. Rev. 11: 65-105.
38. Tato, F., G. L. Vega, and S. M. Grundy. 1995 Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations. Arterioscler. Thromb. Vasc. Biol. 15(4): 446-451.
39. Mann, C. J., F. T. Yen, A. M. Grant, and B. E. Bihain. 1991. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest. 88: 2059-2066.
40. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1994. Human HDL cholesterol levels ate determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arterioscler. Thromb. 14: 707-720.
41. Horowitz, B. S., I. J. Goldberg, J. Merab, T. M. Vanni, R. Ramakrishman, and H. N. Ginsberg. 1993. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J. Clin. Invest. 91: 1743-1752.
42. Lagrost, L., A. Athias, B. Herbeth, V. Guyard-Dangremont, Y. Artur, F. Paille, P. Gambert, and C. Lallemant. 1996. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. J. Biol. Chem. 271: 19058-19065.